These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35316225)

  • 21. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
    Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
    Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment.
    Lee M; Chung GE; Lee JH; Oh S; Nam JY; Chang Y; Cho H; Ahn H; Cho YY; Yoo JJ; Cho Y; Lee DH; Cho EJ; Yu SJ; Lee DH; Lee JM; Kim YJ; Yoon JH
    Hepatology; 2017 Nov; 66(5):1556-1569. PubMed ID: 28617992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
    Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
    Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
    Simon TG; Ma Y; Ludvigsson JF; Chong DQ; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Chung RT; Zhang X; Chan AT
    JAMA Oncol; 2018 Dec; 4(12):1683-1690. PubMed ID: 30286235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study.
    Du ZQ; Zhao JZ; Dong J; Bi JB; Ren YF; Zhang J; Khalid B; Wu Z; Lv Y; Zhang XF; Wu RQ
    World J Gastroenterol; 2019 Jul; 25(28):3798-3807. PubMed ID: 31391774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis.
    Zhang Z; Zhou Y; Yang J; Hu K; Huang Y
    BMC Cancer; 2019 May; 19(1):511. PubMed ID: 31142283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis.
    Jang H; Lee YB; Moon H; Chung JW; Nam JY; Cho EJ; Lee JH; Yu SJ; Kim YJ; Lee J; Yoon JH
    Hepatology; 2022 Aug; 76(2):492-501. PubMed ID: 35100447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection.
    Shen YC; Hsu HC; Lin TM; Chang YS; Hu LF; Chen LF; Lin SH; Kuo PI; Chen WS; Lin YC; Chen JH; Liang YC; Chang CC
    J Clin Oncol; 2022 Apr; 40(11):1206-1219. PubMed ID: 35044851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta-analysis.
    Yuan BH; Li RH; Huo RR; Li MJ; Papatheodoridis G; Zhong JH
    J Gastroenterol Hepatol; 2022 May; 37(5):782-794. PubMed ID: 35080052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study.
    Kim SU; Seo YS; Lee HA; Kim MN; Lee EJ; Shin HJ; Lee YR; Lee HW; Park JY; Kim DY; Ahn SH; Han KH; Um SH; Tak WY; Kweon YO; Kim BK; Park SY
    Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):832-837. PubMed ID: 31988073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis: Association between hepatitis B virus preS mutation and hepatocellular carcinoma risk.
    Wungu CDK; Ariyanto FC; Prabowo GI; Soetjipto S; Handajani R
    J Viral Hepat; 2021 Jan; 28(1):61-71. PubMed ID: 32896077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis.
    Huang ZH; Lu GY; Qiu LX; Zhong GH; Huang Y; Yao XM; Liu XH; Huang SJ; Wu T; Yuan Q; Wang YB; Su YY; Zhang J; Xia NS
    BMC Cancer; 2022 Mar; 22(1):287. PubMed ID: 35300634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.
    Inoue M; Yoshimi I; Sobue T; Tsugane S;
    J Natl Cancer Inst; 2005 Feb; 97(4):293-300. PubMed ID: 15713964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Entecavir vs Tenofovir in Hepatocellular Carcinoma Prevention in Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis.
    Cheung KS; Mak LY; Liu SH; Cheng HM; Seto WK; Yuen MF; Lai CL
    Clin Transl Gastroenterol; 2020 Oct; 11(10):e00236. PubMed ID: 33031195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis.
    Dave S; Park S; Murad MH; Barnard A; Prokop L; Adams LA; Singh S; Loomba R
    Hepatology; 2021 Jan; 73(1):68-78. PubMed ID: 32277491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.
    Cunha V; Cotrim HP; Rocha R; Carvalho K; Lins-Kusterer L
    Ann Hepatol; 2020; 19(3):232-237. PubMed ID: 31836424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis.
    Yang Y; Zhang D; Feng N; Chen G; Liu J; Chen G; Zhu Y
    Gastroenterology; 2014 Nov; 147(5):1031-42. PubMed ID: 25127680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies.
    Chen J; Han Y; Xu C; Xiao T; Wang B
    Eur J Cancer Prev; 2015 Mar; 24(2):89-99. PubMed ID: 24809655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.
    Wang P; Wu C; Li Y; Gong Y; Shen N
    Gene; 2020 Jun; 742():144585. PubMed ID: 32173542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.